Pure Global
CDSCO UID IMP/IVD/2021/000290_6e3009cd090d7d12638276efe9c8abc5_be68a53de5e71e6ae0c211863264b2d3

SARS-CoV-2 Antigen Test Kit

Regulatory1·Device Class Class C·India CDSCO·Brand: LFIA
Registration details
UID
IMP/IVD/2021/000290_6e3009cd090d7d12638276efe9c8abc5_be68a53de5e71e6ae0c211863264b2d3
Device class
Class C
Brand name
LFIA
License holder
Regulatory1
Approving authority
CDSCO
Product information
SARS-CoV-2 antigen Test Kit (LFIA) is used to qualitatively detect SARS-CoV-2 inhuman samples in vitro.
Other products from Regulatory1
Products from the same license holder (2 products)
Pre-fillable glass barrel with needle
Brand: ZEMLEY
Class B
Coronavirus
Brand: 2019-nCoV
Class C
About this record

SARS-CoV-2 Antigen Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000290_6e3009cd090d7d12638276efe9c8abc5_be68a53de5e71e6ae0c211863264b2d3. This device is marketed under the brand name LFIA. The license holder is Regulatory1, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.